Strategic Partnerships
A TRUSTED PARTNER
PathoQuest is a global CRO that harnesses the power of Next Generation Sequencing and GMP assays to provide Quality Control Testing of biopharmaceuticals.
We are trusted by customers and partners alike to implement GMP NGS solutions because of our experience and expertise.
Together, we are committed to accelerating the development and delivery of innovative treatments.
- Global leader in biosafety
- Turnkey Solution: Our strategic partnership with Charles River Laboratories means that customers can outsource a full QC package under one contract, and managed by a single point of contact.
“Our partnership with PathoQuest is integral to our ability to provide the most sensitive testing methods to our clients in order to ensure the safety of biological products produced by the biopharmaceutical industry.”
Kerstin Dolph
Senior Vice President, Biologics Solutions
at Charles River Laboratories
- Global leader in NGS
- Co-development and commercialization agreement
“We are excited to be working with PathoQuest to develop and offer the first Good Manufacturing Practice (GMP) accredited Integration Site Analysis test with nanopore sequencing. We believe this will have a significant future impact by improving test accuracy and turnaround times for genetic characterisation for multiple applications in biopharma.”
Gordon Sanghera
CEO at Oxford
Nanopore Technologies
Contact us
France
+33 (0)1 70 82 17 90
Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France
How can PathoQuest help?
U.S.
466 Devon Park Dr
Wayne, PA 19087
United States
France
+33 (0)1 70 82 17 90
Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France
How can PathoQuest help?
Sign up for our latest news
